Our group’s focus, as part of the Center for Vector-Borne Infectious Diseases (CVID), is understanding how RNA viruses replicate at the molecular and biochemical levels in order to develop novel strategies for the prevention and treatment of arboviral diseases. We are also interested in developing novel virus-based tools that can be used by the wider scientific community. We use a wide range of tools (classical virology, molecular biology, cell biology, biochemistry, engineering, computational biology, etc.) to understand how these important human pathogens replicate and use this information to help improve human and animal health.
Dr. Brian Geiss is the Director of the Master of Science in Microbiology – Immunology program. This nine-month, non-thesis program is designed to strengthen the scientific academic portfolio of those seeing terminal professional degrees and provide preparation for those seeking careers in biotechnology and research.
People
Principal Investigator (PI)
Associate Professor
Director of Microbiology- Immunology Master's Program
news and updates view all
What is it that puts older people at increased risk from viruses like SARS-CoV-2?
The CSU developed COVID-19 biosensor test could produce results from blood, saliva or nasal swab sample in 30 minutes at home for a low cost.
Geiss Lab distribution of virus infectious clone expression plasmids (Zika, Sindbis, etc.).
contact information
Lab: Microbiology Room B430
Office: Microbiology Room B409
(970) 491-6330
brian.geiss@colostate.edu